Other Content - BioPharm International

ADVERTISEMENT

Other Content

SGS - CONFIDENCE IN BIOLOGICS FORMULATION DESIGN

September 20, 2013

SGS - CONFIDENCE IN BIOLOGICS FORMULATION DESIGN

FDA Specifies Unique Facility Identifier System

September 11, 2013

FDA specifies the DUNS UFI system for registration of domestic and foreign drug establishments.

FDA Announces More Compounding Pharmacy Recalls

September 9, 2013

FDA inspections reveal possible inaccurate sterility testing.

Novartis Receives EU Approval for Juvenile Arthritis Treatment

September 4, 2013

Novartis Ilaris, an interleukin-1 beta inhibitor, treats active system juvenile idiopathic arthritis.

BioPharm December 2012 BPA

September 1, 2013

BioPharm December 2012 BPA

BioPharm 2014 Media Kit

September 1, 2013

BioPharm 2014 Media Kit

FDA and EMA Publish Assessment of QbD for Marketing Applications

August 20, 2013

Agencies collaborate to ensure consistent product quality.

FDA Reviews Outdated Guidance Documents

August 14, 2013

CDER withdraws some outdated guidance documents and makes plans to finalize others.

Onyx Rejects Amgen’s Unsolicited Acquisition Bid

July 2, 2013

The Onyx board of directors rejects $120-per-share proposal as significantly undervaluing the company.

ADVERTISEMENT

ADVERTISEMENT

Click here